{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-022488","form_type":"8-K","ticker":"STXS","cik":"0001289340","company_name":"Stereotaxis, Inc.","filed_at":"2026-05-12T20:10:47+00:00","discovered_at":"2026-05-12T20:12:00.537372+00:00","generated_at":"2026-05-12T20:59:39.638277+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stereotaxis reports Q1 revenue $6.3M, net loss $5.9M; guides FY26 rev >$40M; MAGiC FDA approved, Robocath acquisition","bullets":["Revenue $6.3M vs $7.5M YoY; net loss $5.9M; cash $14.6M, no debt.","MAGiC catheter (FDA approved Jan) and Synchrony system (FDA cleared Apr) now in commercial use.","Definitive agreement to acquire Robocath, combining complementary robotic technologies.","Guides FY26 revenue >$40M, double-digit growth; Q3 and Q4 each >$10M.","Manufacturing ramp for MAGiC targets 500/month by year end; winding down J&J relationship."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-022488","json":"https://secwatch.observer/filing/0001493152-26-022488.json","markdown":"https://secwatch.observer/filing/0001493152-26-022488.md","text":"https://secwatch.observer/filing/0001493152-26-022488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289340/000149315226022488/0001493152-26-022488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289340/000149315226022488/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T20:59:39.638277+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}